Dr. Reddy's Laboratories Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $13.85 | $15.98 | $14.70 |
| Q2 2024 | 1 | $15.10 | $17.42 | $16.02 |
| Q3 2024 | 1 | $16.28 | $18.78 | $17.28 |
| Q4 2024 | 2 | $17.06 | $19.58 | $18.01 |
| Q1 2025 | 2 | $17.01 | $19.06 | $18.06 |
| Q2 2025 | 1 | $16.79 | $19.38 | $17.82 |
| Q3 2025 | 1 | $16.76 | $19.34 | $17.79 |
| Q4 2025 | 1 | $13.41 | $15.47 | $14.23 |
| Q1 2026 | 1 | $14.98 | $17.29 | $15.91 |
Dr. Reddy's Laboratories Limited Earnings Date And Information
Dr. Reddy's Laboratories Limited last posted its earnings results on Tuesday, November 5th, 2024. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.04434 by $0.00434. The company had revenue of 76.73 B for the quarter and had revenue of 279.16 B for the year. Dr. Reddy's Laboratories Limited has generated $335 earnings per share over the last year ($334.59 diluted earnings per share) and currently has a price-to-earnings ratio of 3.82. Dr. Reddy's Laboratories Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Dr. Reddy's Laboratories Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/12/2024 | Q1 2025 | $83.59 | $72.98 B | $76.73 B | ||
| 06/12/2024 | Q4 2024 | $78.49 | $70.83 B | |||
| 06/12/2024 | Q3 2024 | $82.81 | $72.15 B | |||
| 09/30/2023 | Q2 2024 | $88.96 | $67.88 B | $68.80 B | ||
| 06/13/2023 | Q1 2024 | $84.21 | $63.79 B | $67.38 B | ||
| 06/13/2023 | Q4 2023 | $57.79 | $62.97 B | |||
| 06/13/2023 | Q3 2023 | $75.53 | $67.70 B | |||
| 09/12/2022 | Q2 2023 | $67.40 | $56.69 B | $63.06 B | ||
| 06/27/2022 | Q1 2023 | $71.56 | $53.61 B | $52.15 B | ||
| 06/27/2022 | Q4 2022 | $5.27 | $54.37 B | |||
| 11/08/2021 | Q3 2022 | $42.58 | $53.20 B | |||
| 11/08/2021 | Q2 2022 | $59.80 | $51.74 B | $57.63 B | ||
| 06/30/2021 | Q1 2022 | $34.44 | $50.45 B | $49.19 B | ||
| 06/30/2021 | Q4 2021 | $33.38 | $47.28 B | |||
| 06/30/2021 | Q3 2021 | $1.19 | $49.30 B | |||
| 09/29/2020 | Q2 2021 | $45.96 | $47.02 B | $48.97 B | ||
| 06/15/2020 | Q1 2021 | $34.94 | $41.68 B | $44.18 B | ||
| 06/15/2020 | Q4 2020 | $46.10 | $44.32 B | |||
| 06/15/2020 | Q3 2020 | -$34.37 | $43.84 B | |||
| 09/29/2019 | Q2 2020 | $65.93 | $42.07 B | $48.01 B |
Dr. Reddy's Laboratories Limited Earnings: Frequently Asked Questions
-
When is Dr. Reddy's Laboratories Limited's earnings date?
Dr. Reddy's Laboratories Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
How can I listen to Dr. Reddy's Laboratories Limited's earnings conference call?
The conference call for Dr. Reddy's Laboratories Limited's latest earnings report can be listened to online.
-
How can I read Dr. Reddy's Laboratories Limited's conference call transcript?
The conference call transcript for Dr. Reddy's Laboratories Limited's latest earnings report can be read online.
-
How much revenue does Dr. Reddy's Laboratories Limited generate each year?
Dr. Reddy's Laboratories Limited (:RDY) has a recorded annual revenue of $279.16 B.
-
How much profit does Dr. Reddy's Laboratories Limited generate each year?
Dr. Reddy's Laboratories Limited (:RDY) has a recorded net income of $279.16 B. Dr. Reddy's Laboratories Limited has generated $335.22 earnings per share over the last four quarters.
-
What is Dr. Reddy's Laboratories Limited's price-to-earnings ratio?
Dr. Reddy's Laboratories Limited (:RDY) has a price-to-earnings ratio of 3.82 and price/earnings-to-growth ratio is -20.61.
